No title
BackgroundPrimary care is key to early identification and referral of patients with Alzheimer’s disease (AD). Assessing eligibility for new anti-amyloid treatment may guide appropriate referrals and prevent overburdening specialized care. In this study we determined eligibility for anti-amyloid treatment in patients undergoing cognitive evaluation in primary care.MethodPatients were selected from
